February 20, 2017

Biotechnology, Life Sciences, Food and Drug Law News

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals.  Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market.  Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date Title Organization
17
Feb
CDC Issues New Guidance For Use of EPA-Registered Disinfectants in Environmental Control of Candida auris for U.S. Healthcare Facilities Bergeson & Campbell, P.C.
17
Feb
The Uncertain Legal Future of Wine Direct Shipping by the Retail Tier McDermott Will & Emery
17
Feb
Monsanto Uses the Constitution to Challenge Warning Labels for Herbicide Schiff Hardin LLP
17
Feb
Center for Food Safety and Applied Nutrition's Export Certificates Go Electronic Keller and Heckman LLP
17
Feb
Legislation to Expand Lending for NJ Vineyards and Wineries Stark & Stark
16
Feb
Tenth Circuit Upholds Discharge of Employee in Safety-Sensitive Position Who Tested Positive for Cocaine Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
16
Feb
FDA Announces Public Meeting to Obtain Input on Use of Term “Healthy” in Labeling of Human Food Keller and Heckman LLP
15
Feb
State Legislators File Amicus Brief Against Philadelphia Beverage Tax Keller and Heckman LLP
14
Feb
NIOSH Seeks Comment on Proposed Survey of Engineered Nanomaterial OSH Practices Bergeson & Campbell, P.C.
14
Feb
Predictable and Predicted: Whistleblower Suit Filed Under FSMA Michael Best & Friedrich LLP
14
Feb
New Study Targets Fluorinated Grease-Proofing Agents Employed in Paper Packaging for Fast Food Keller and Heckman LLP
14
Feb
European Commission: Nanomaterials Inventory for Cosmetics Will Be Published “in the Next Weeks” Bergeson & Campbell, P.C.
13
Feb
FDA Devices Center Issues Multiple Guidances in the Obama Administration’s Final Months Morgan, Lewis & Bockius LLP
13
Feb
Oregon Contemplates GMO Ban Keller and Heckman LLP
13
Feb
House Agriculture Committee to Debate SNAP Purchase Restrictions Squire Patton Boggs (US) LLP
13
Feb
Food and Drug Administration Hits “Pause” on Regulation of Laboratory Developed Tests Foley & Lardner LLP
10
Feb
USDA Extends Comment Period for Proposed Rule to Revamp Its Biotechnology Regulations Keller and Heckman LLP
10
Feb
New Drug Application Conflict Preemption Defense Gains Traction in Utts v. Bristol-Myers Squibb Co. Barnes & Thornburg LLP
10
Feb
Consumer Specialty Products Association Sends Letter To Trump On Safer Choice Program Bergeson & Campbell, P.C.
10
Feb
The Alcohol & Tobacco Tax & Trade Bureau Proposes New Definition of Hard Cider McDermott Will & Emery

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS